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Abstract
OBJECTIVE: Sui Zheng Shi Liang strategy (regulat-
ing prescription dosage with different syndromes)
is an important part of syndrome differentiation
and treatment in Traditional Chinese Medicine
(TCM). Questionnaires were given to doctors and
patients to study the essential factors (indicators
and timing) of Sui Zheng Shi Liang strategy in the
treatment process of type 2 diabetes (T2DM).
METHODS: Two questionnaires were designed for
diabetes patients and their doctors. The question-
naires included the most important indicators for
determining the patient's condition, the ability of
TCM in treating T2DM, the length of time it takes
for TCM to be effective, and when to adjust the pre-
scription dosage. The frequency of answers was cal-
culated, summarized, and analyzed after the survey.
RESULTS: Twenty questionnaires from doctors and
90 questionnaires from patients were included in
the analysis. Doctors and patients recognized that
TCM could decrease blood glucose, improve syn-
dromes, and delay complications. Doctors were
mainly concerned about glycosylated hemoglobin,
while the patients were concerned about fasting
plasma glucose for determining whether treatment
was effective. Doctors also paid attention to chang-
es in blood sugar and syndromes 2 weeks after
medication was given as the indication to adjust
the prescription dosage, while patients were con-
cerned about these factors in 4 weeks. The prescrip-
tion should be regulated when there are side ef-
fects or the medication is ineffective.
CONCLUSION: The essential factor in the treat-
ment process of T2DM in Sui Zheng Shi Liang strat-
egy is that if fasting blood glucose level did not de-
crease after 4 weeks of treatment, the Chinese med-
icine prescription should be adjusted.
© 2013 JTCM. All rights reserved.
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INTRODUCTION
Sui Zheng Shi Liang strategy (regulating dose with dif-
ferent syndromes) is an important part of syndrome
differentiation and treatment in Traditional Chinese
Medicine (TCM). Sui Zheng Shi Liang strategy is re-
flected in the response of patients to medication and
the treatment activities of doctors. To clarify the specif-
ic expression of these two essential factors, it is neces-
sary to investigate the cognitive status of diseases, and
the confidence and expectations of TCM treatment of
patients and their doctors.
Type 2 diabetes (T2DM) is a chronic disease. A long
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time is needed to observe the prognosis of T2DM. Gly-
cated hemoglobin (HbA1c), which is currently the
most frequently used indicator for evaluating the effica-
cy of drug therapy for T2DM, is not the final indicator
at endpoint, but an alternative indicator proved by evi-
dence-based medicine. 20 years ago, the most acknowl-
edged indicators for efficacy of drug therapy for
T2DM are fasting blood glucose and 2-hour postpran-
dial blood glucose. Fasting blood glucose and 2-hour
postprandial blood glucose reflect the instant blood glu-
cose level, and HbA1c reflects the average blood glucose
level of the last month.1,2 For patients, clinical symp-
toms need to be treated, as well as high blood glucose
levels. Fasting blood glucose, 2-hour postprandial blood
glucose, HbA1c, and clinical symptoms are considered
as indicators to evaluate diseases. However, it is un-
known which factor is the most important for observa-
tion, which factor needs to be considered to evaluate
drug efficiency, and which factor needs to be considered
to adjust the prescription and dose of TCM. The opin-
ions of patients and doctors on these issues need to be in-
vestigated.
Drugs need to be administered for a certain amount of
time for efficacy. During a long medication treatment
time, it is important to determine when patients expect
to interact with physicians, and when and under what
circumstances do the patients and doctors want to ad-
just the prescription and dosage of TCM.
In the current study, two questionnaires were designed
to investigate patients and doctors separately. Accord-
ing to the literature and clinical practice,3-7 the compo-
sition of the questionnaires included 4 parts. 1) Cogni-
tive status of T2DM: Diagnostic indicators, prognostic
indicators, efficacy evaluation indicators, and efficacy
evaluation time were included in this part of the ques-
tionnaire. Fasting blood glucose, 2-hour postprandial
blood glucose, HbA1c, dry mouth/thirst, polyuria,
polydipsia, hyperphagia, urine sugar, urine protein, up-
set stomach, blood lipids, blood pressure, and medica-
tion treatment time were listed as choices. 2) Cognitive
status of the role TCM plays in treating T2DM: Treat-
ment orientation and therapeutic targets were includ-
ed. Reducing blood glucose, improving symptoms, pre-
venting complications, and treating complications were
listed as choices. 3) The indicators can be improved by
TCM and the indicators expected to be improved by
both patients and doctors. 4) The length of time TCM
improves the main indicators, the length of durable
useless time, the length of expected and accepted
times, and circumstances for adjusting prescriptions
were listed.
METHODS
Objective of the study
T2DM patients and doctors were studied. Respondent
sources included six hospitals of TCM of Beijing and
Tianjin, including four grade 3 and first-class hospitals,
and two community hospitals.
Inclusion criteria
Doctors: subjects were Chinese physicians who had en-
gaged in clinical medicine for longer than 2 years.
They had to be able to recognize the efficacy of TCM
in T2DM, treated T2DM patients with TCM often in
clinical work, and were interested in this study.
Patients: T2DM patients who met the diagnostic crite-
ria of the World Health Organization in 1999 were in-
cluded in the study.8 They had to believe that TCM is
effective in treating T2DM. They were using or had
used TCM to treat T2DM. Those patients who suf-
fered from serious complications or suffered from se-
vere cardiovascular complications, cancer, kidney dis-
ease, eye disease, or digestive system or blood system
diseases, were not included in the study.
Questionnaire items
Doctors: the questionnaire content to doctors included
the following. 1) Length of career time: "How many
years have you engaged in TCM clinical practice?" 2)
Important indicators: "As a Chinese medicine doctor,
what indicators are you mostly concerned about in
T2DM treatment?" 3) Recognition of TCM treatment
for T2DM: "Do you think that TCM can treat T2DM
alone?" 4) The role that TCM plays in T2DM treat-
ment: "Do you think that TCM can lower blood sugar?
", "Can TCM improve symptoms?", and "Can TCM
delay complications or have no effect in the treatment
of T2DM? 5) Indicators improved by TCM: "What in-
dicators can be improved by TCM in your opinion?"
6) Length of time for adjusting the prescription: "How
long do you think that a TCM prescription needs to be
adjusted?" 7) When to adjust the prescription of TCM:
"Which conditions need to be considered when you ad-
just the prescription?"; "When the prescription is effec-
tive?", "When the prescription has no effect?", "When
the prescription shows side effects?" or "Other condi-
tions (please fill in the blank)?" 8) Recognition of the
length of onset time: "How long do you think it takes
for TCM to show an effect?"Patients: the questionnaire
content to patients included the following. 1) Course
of the disease: "How many years have you been suffer-
ing from diabetes?" 2) Combined diseases: "What dis-
eases are you suffering from besides T2DM? 3) Impor-
tant indicators: "As a patient, what indicators are you
mostly concerned about in T2DM treatment?" 4) Rec-
ognition of TCM treatment of T2DM: "Do you think
that TCM can treat T2DM alone?" 5) Indicators im-
proved by TCM: "What indicators do you expect to
mostly be improved by TCM in your opinion?" 6)
Length of time for adjusting the prescription: "How
long do you think that the TCM prescription needs to
be adjusted?" 7) When to adjust the prescription of
TCM: "Which conditions do you think need to be
considered when you adjust the prescription?"; "When
the prescription is effective?", "When the prescription
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has no effect?", When the prescription shows side ef-
fects?" or "Other conditions (please fill in the blank)?"
8) Recognition of the length of time for effectiveness
of TCM: "How soon do you expect the TCM treat-
ment to show an effect?"
Sample size
Twenty clinical physicians and 90 diabetes patients
were surveyed in the study.
Statistical analyses
All of the outcome data were transferred via double en-
try into EpiData 3.1 (EpiData Association, Denmark).
After cleaning and validation, two databases were estab-
lished, including a doctors' database and patients' data-
base. SPSS 12.0 software (SPSS Inc.) was used to ana-
lyze the data. The frequency of answers from physi-
cians and patients for each question was calculated and
analyzed.
RESULTS
Questionnaires for doctors
Baseline data: a total of 21 questionnaires were sent
out and returned. One questionnaire was excluded for
missing too much information. Therefore, 20 question-
naires were included in the study. The doctors investi-
gated included nine male doctors and 11 female doc-
tors. The ages of doctors ranged from 27 years to 48
years, and the mean age was (37±7) years,. The doc-
tors' career times ranged from 2 to 25 years, with a
mean time of (13±2) years. All of the doctors had used
TCM in clinical practice.
Cognitive status of current treatment and TCM treat-
ment of T2DM: according to the answers to the ques-
tionnaire, doctors were mostly concerned about
HbA1c. With increasing years of the physician's experi-
ence, doctors paid more attention to blood glucose.
Doctors recognized that TCM can reduce blood glu-
cose levels, improve symptoms, and delay complica-
tions. These effects manifested in reducing HbA1c,
fasting blood sugar, and proteinuria.
1) Important indicators: for a diagnostic indicator of
diabetes, disease indicators, and the main common dia-
betes clinical symptom, HbA1c was considered as the
most important indicator by 90% doctors. A total of
10% of doctors also considered that fasting blood glu-
cose was important.
2) Cognitive status of the role the TCM plays in treat-
ing T2DM: a total of 60.0% of doctors considered
that TCM can treat T2DM alone. Most doctors
thought that TCM reduces blood glucose levels, im-
proves symptoms, and delays complications. For im-
proving symptoms, TCM was the most used and the
best option (Table 1).
Most doctors thought that TCM reduces HbA1c and
fasting blood sugar, reduces dry mouth/thirst symp-
toms, and improves urinary protein levels (Table 1).
Essential factors (indicators and adjustment time of
prescriptions) of Sui Zheng Shi Liang strategy: most
doctors thought that if an effect of TCM was not ap-
parent by 2 weeks, the TCM prescription needed to be
adjusted. When a significant effect or a side effect was
observed in 2 weeks, the TCM prescriptions also need-
ed to be adjusted.
1) Cognitive status of the length of time to adjust pre-
scriptions: doctors thought that prescriptions needed to
be adjusted in 1 to 8 weeks. The average adjustment time
was (2.3 ± 1.6) weeks. Most doctors thought that 2
weeks was an appropriate time to adjust prescriptions
(Table 2).
2) When to adjust the prescription of TCM: most
doctors (80.0% ) thought that TCM prescriptions
should be adjusted when there was no efficacy. Signif-
icant efficacy and side effects were also considered to
be appropriate circumstances to adjust the prescrip-
tion (Table 3).
Question
The role Chinese medicine plays
in type 2 diabetes treatment
The indicators can be improved
by Chinese medicine
Option
Lowering blood sugar
Improving the symptoms
Delaying the complications
FPG
2-hour PG
HbA1c
Dry mouth / thirst symptoms
Urinary protein
Selected number
17 (85.0%)
19 (95.0%)
17 (85.0%)
6
1
7
4
2
First selected number
6 (30.0%)
9 (45.0%)
5( 25.0%)
-
-
-
-
-
Table 1 Cognitive status of the role that TCM plays in treating T2DM
Notes: FPG: fasting blood glucose; 2-hour PG: 2-hour postprandial blood glucose; HbA1c: glycated hemoglobin.
Doctor level
Primary
Middle
Advanced vice
Advanced
Total
n
3
7
7
2
19
Prescription dosage adjust time
(week)
1.7±0.6
2.0±0.8
3.0±2.4
1.8±0.4
2.3±1.6
Table 2 Mean time for adjusting the prescription dosage of
different levels of doctors ( xˉ ±s)
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3) The length of time for TCM to be effective: the aver-
age length of time that it took for TCM to be effective
was just over 2 weeks for treating diabetes. Most doc-
tors thoughtTCMwould work in 2 to 4 weeks, and some
doctors thought that 1weekwas effective (Tables 4).
4) Comprehensive analysis of the essential factors of
Sui Zheng Shi Liang strategy: after analyzing the im-
portant indicators of T2DM, the role that TCM plays
in treatment of T2DM, the time for effectiveness of
TCM, and when prescriptions should be adjusted, our
results indicated that, when treating T2DM with
TCM, a change in HbA1c was the most important in-
dicator of an effect by doctors. Blood glucose levels and
symptoms should also be evaluated every 2 weeks. If
blood glucose levels and symptoms did not significantly
change or there was a side effect, doctors should adjust
the prescription dosage (Table 5).
Research on patients
Baseline data: a total of 95 questionnaires were sent
out and returned. Two of these questionnaires were ex-
cluded for missing too much information. Therefore,
93 questionnaires were included in the study. Patients
included 56 males and 37 females. The ages of patients
ranged from 34 to 77 years, and the mean age was (55±
10) years. Courses of disease ranged from 1 month to
23 years, and the mean time was (7±6) years. Most pa-
tients also had other diseases besides T2DM. All of the
patients had been or were treated by TCM (Tables 6).
Cognitive status of current treatment and TCM treat-
ment of T2DM: according to the answers from the
questionnaires, patients were mostly concerned about
blood glucose levels. Most patients thought that TCM
reduces blood glucose levels. They expected that TCM
will reduce fasting blood glucose and 2-hour postpran-
Table 3 Occasions to adjust the prescription according to the level of doctor
Doctor level
Primary
Middle
Advanced vice
Advanced
Total
n
3
8
7
2
20
Effect
0
3
2
0
5
No effect
3
5
6
2
16
Side effect
0
2
3
0
5
No side effect
0
1
1
0
2
Others
0
1a
1a
0
2
Note: athe specific answer was periodic adjustment.
Table 4 Length of time for TCM to be effective for treating diabetes ( xˉ ±s)
Doctor level
Primary
Middle
Advanced
vice
Advanced
Total
n
3
8
7
2
2
0
≤1
week
0
3
1
0
4
1-2
weeks
1
2
1
2
6
2-3
weeks
0
0
1
0
1
3-4
weeks
1
2
4
0
7
Others
1
1
0
0
2
Average onset
time (week)
3.0±1.4
2.1±1.4
3.1±1.3
1.8±0.4
2.5±1.3
Other answer
It varies according to different
conditions (1 case)
It varies according to different
conditions (1 case)
-
-
-
Table 5 Comprehensive analysis of the essential factors of Sui Zheng Shi Liang strategy
Item
Concerned indictors
The role of Traditional Chinese Medicine plays
Onset time
Time to adjust prescription dosage
Occasions to adjust prescription dosage
The main answer in the survey
HbA1c 18 (90.0%)
Reduce the blood glucose 17 (85.0%); Improve the symptoms 19 (95.0%);
Delay the complications 17 (85.0%)
2-4 weeks
2 weeks
No effect, significant effect, side effect
Note: HbA1c: glycated hemoglobin.
Table 6 Types of other diseases and Combination in type 2 diabetes patients
n
93
Hypertention
41
Dyslipidemia
45
High uric acid
8
Coronary
heart disease
14
Brain infarction
11
Obesity
12
Other disease
6
n
93
None
19
Combined 1
disease
33
Combined 2
diseases
19
Combined 3
diseases
12
Combined 4
diseases
9
Combined 5 diseases
or more
1
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dial blood glucose, reduce glycated hemoglobin, and
improve symptoms and complications.
1) Analyzing important indicators of T2DM: after eval-
uating diagnostic indicators, prognostic indicators, effi-
cacy evaluation indicators, and main clinical symp-
toms, the most important indicator was fasting blood
glucose. This was followed by HbA1c, 2-hour post-
prandial blood glucose, and complications (Table 7).
2) Cognitive status of the role that TCM plays in treat-
ing T2DM: a total of 69.9% patients considered that
TCM alone can treat T2DM. Most patients thought
that TCM reduces blood glucose levels, improves symp-
toms, and delays complications (Table 7).
Essential factors (indicators and adjustment time of
prescriptions) of Sui Zheng Shi Liang strategy: most pa-
tients thought that if there was no effect by 4 weeks,
the TCM prescription needed to be adjusted. When
there was a significant effect or a side effect, TCM pre-
scriptions also needed to be adjusted.
1) Expected adjustment time for prescriptions: patients
thought that prescriptions needed to be adjusted in
1-48 weeks, with a mean time of (6±7) weeks. Most pa-
tients thought that 4 weeks was the most appropriate
time to adjust a prescription. A total of 68.8% of an-
swers were less than 4 weeks. Four patients chose to fol-
low the prescription (Tables 8-9). 2) When to adjust
the prescription of TCM: most patients (66.7% )
thought that TCM prescriptions should be adjusted
when there was no efficacy. Significant efficacy and
side effects were also reasons for adjusting the prescrip-
tion (Table 10). 3) Expectation of the length of time
for effectiveness of TCM: most patients expected that
TCM would work in 2 to 4 weeks, and some patients
thought that 24 weeks was acceptable (Tables 11). 4)
Comprehensive analysis of the essential factors of Sui
Zheng Shi Liang strategy: after analyzing the impor-
tant indicators of T2DM, the role that TCM plays in
the treatment of T2DM, the time for effectiveness of
TCM, and when to adjust prescriptions, our results in-
dicated that, when treating T2DM with TCM, a
change in HbA1c was the most important indicator of
an effect of TCM by patients. Blood glucose levels and
symptoms should also be evaluated every 2 weeks. If
blood glucose levels and symptoms did not significant-
ly change, or if there was a side effect, patients wanted
their doctors to adjust the prescription dosage (Table
12).
DISCUSSION
Sui Zheng Shi Liang strategy can be shown very clearly
in the course of treatment in clinical practice, especial-
ly a long course of treatment of chronic diseases, the
prescription and dosage of TCM should be adjusted at
a specific time and circumstance according to the dif-
ferent characteristics of different patients after the ini-
tial TCM treatment.
The essential factors of Sui Zheng Shi Liang strategy in-
clude an indicator and occasion. These factors vary ac-
cording to different patients' conditions. These factors
should first be investigated by epidemiological studies
with both doctors and patients. The study result
should then be validated through evidence-based medi-
cine research. This is an important part of moderniza-
tion of TCM.
With the development and use of modern medicine,
the content of syndrome differentiation includes a
physical examination and laboratory test results of
modern medicine, as well as the history, symptoms,
tongue, and pulse, which originally are part of TCM.
This new content should be included in modern Chi-
nese medicine research.
Taking the treatment of T2DM for example, in 1999,
the World Health Organization provided diagnostic cri-
teria of diabetes as follows: fasting plasma glucose ≥
7.0 mmol /L, 2-hour postprandial blood glucose ≥
11.1 mmol/L, or random blood glucose ≥11.1 mmol/L.
The studys found that blood glucose is easily affected by
large fluctuations. Blood glucose cannot fully reflect
Table 7 Important indicators of type 2 diabetes for patients
Question
What do you
concern to the type
2 diabetes
What indicators do
you expect mostly
to be improved by
Chinese medicine
Option
FPG
2-hour PG
HbA1c
Complications
Blood lipid
Blood pressure
Dry mouth /
thirst symptoms
Insomnia
Urinary protein
Hyperphagia
Others
FPG
2-hour PG
HbA1c
Dry mouth /
thirst symptoms
Urinary protein
Hyperphagia
Others
Selecte Number
35 (37.6%)
12 (12.9%)
23 (24.7%)
8 (8.6%)
1
1
4
1
3
2
11
42 (45.2%)
8
24 (25.8%)
4
5
1
9
Notes: FPG: fasting blood glucose; 2-hour PG: 2-hour
postprandial blood glucos; HbA1c: glycated hemoglobin.
Table 8 Expected time to adjust prescriptions ( xˉ ±s)
n
86
Prescription adjusting time
(week)
6±7
Other answers
Not sure
Do not know
Follow the prescribed
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the level of glycemic control. HbA1c reflects the past 3
months' average blood sugar condition. HbA1c is also
positively correlated with the occurrence and outcome
of diabetic microangiopathy. Therefore, the indicator
of HbA1c has attracted attention during the treatment
of diabetes by doctors.
However, HbA1c in blood must be tested using venous
blood in medical institutions with large equipment.
Blood glucose is easily measured through fingertip blood
with a family-type apparatus, which is widely used.
Therefore, blood sugar ismore popularwith patients.
A total of 65% of T2DM patients died from diseases
of the great vessels, including cardiovascular diseas.9 In
2008, several clinical trials on blood glucose and diabet-
ic vascular were published, including action in diabetes
and vascular disease: preterax and diamicron modified
release controlled evaluation (ADVANCE), action to
control cardiovascular risk in diabetes (ACCORD), vet-
eran affairs diabetes trial (VADT), and UKPDS trials.
The primary endpoint of these trials was the incidence
of macrovascular disease. The results showed that there
was no significant difference between the intensive glu-
cose control group and the standard treatment group
in the primary endpoint. 9-12 However, the incidence of
low blood glucose and low blood glucose due to the
rate of death in the intensive glucose control group was
much higher than that in the control group. This result
caused concern for doctors regarding patients' blood
glucose levels, as well as the compliance of HbA1c.
Based on our questionnaire results, the status of doc-
tors and patients concerning diabetes indicators fit the
actual situation and development of modern medicine.
Doctors were primarily concerned about HbA1c, while
patients were mostly concerned about blood glucose.
In the treatment of diabetes, doctors believed that
TCM improves symptoms, reduces blood glucose lev-
els, and delays complications. In clinical practice, doc-
tors need to reduce HbA1c, lower fasting blood glu-
cose, and improve clinical symptoms. Patients expected
that Chinese medicine would reduce fasting blood glu-
cose, followed by lower HbA1c, and an improvement
in complications. The wishes of both doctors and pa-
tients were similar.
The current study showed that doctors and patients
hoped to adjust the prescription in a certain period of
time to obtain clinical efficacy or reduce side effects.
An adjustment was still necessary when an effect ap-
peared.
We found that doctors and patients slightly disagreed
on the length of time it took for TCM to be effec-
tive. The patients' expectation times for effectiveness
of TCM were broad, with some patients expressing
the hope of "the sooner the better" for an effect of
TCM. Some patients were patient, accepting that
treatment could take longer than 6 months. The
time of effectiveness of TCM recognized by doctors
was concentrated in 4 weeks. More than half of the
doctors thought that a prescription should be effec-
tive within 2 weeks. If no effect occurred, the pre-
scriptions needed to be adjusted.
The survey sample was small, which is a limitation
of the study. However, the essential factors (indicator
and timing) of Sui Zheng Shi Liang strategy in the
treatment of T2DM was found in our study. If fast-
ing blood glucose is not reduced after 4 weeks of
treatment, then the TCM prescription should be ad-
justed.
Table 9 Distribution of the expected time for effectiveness of the TCM prescription
n
93
1 week
4
2 weeks
14
4 weeks
46
8 weeks
6
12 weeks
10
24 weeks
5
48 weeks
1
Others
7
Table 10 Reasons for adjusting the prescription
n
93
Effect
24
No effect
62
Side effect
10
No side effect
2
Others
5
n
93
≤1
week
10
1-2
weeks
8
2-3
weeks
1
4
weeks
22
8
weeks
7
12
weeks
13
24
weeks
17
48
weeks
7
Onset time (week)
13±13
Others
As soon as possible
(8 cases)
Table 11 Expectation of the length of effectiveness of TCM ( xˉ ±s)
Table 12 Comprehensive analysis of the essential factors of Sui Zheng Shi Liang strategy
Item
Concerned indictors
The role of traditional chinese medicine plays
Onset time
Time to adjust prescription dosage
Occasions to adjust prescription dosage
Main answer in the survey
FPG 35(37.6%); HbA1c 23 (24.7%)
Reduce the fasting blood glucose 42 (45.2%); Reduce the HbA1c 24 (25.8%)
≤2 weeks
4 weeks
No effect, significant effect, side effect
Notes: FPG: fasting blood glucose; HbA1c: glycated hemoglobin.
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